Mallinckrodt plc (MNKKQ) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.02. It has a SharesGrow Score of 46/100, indicating a mixed investment profile with 1 out of 7 criteria passed.
Financials: revenue is $2.0B, -13.5%/yr average growth. Net income is $478M, growing at +65.5%/yr. Net profit margin is 24.1% (strong). Gross margin is 41.8% (-3.1 pp trend).
Balance sheet: total debt is $913M against $1.6B equity (Debt-to-Equity (D/E) ratio 0.55, moderate). Current ratio is 3.78 (strong liquidity). Debt-to-assets is 27.7%. Total assets: $3.3B.
Analyst outlook: 0 / 3 analysts rate MNKKQ as buy (0%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 25/100 (Fail), Health 50/100 (Partial), Moat 46/100 (Partial), Future 20/100 (Fail), Income 85/100 (Pass).
